Amicus Therapeutics
FOLD
#3908
Rank
S$3.95 B
Marketcap
S$12.83
Share price
-0.50%
Change (1 day)
-1.80%
Change (1 year)

Amicus Therapeutics (FOLD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.82 Billion

According to Amicus Therapeutics 's latest financial reports the company's total liabilities are S$0.82 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Amicus Therapeutics - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.80 B-1.53%
2023-12-31S$0.81 B1.23%
2022-12-31S$0.80 B-0.28%
2021-12-31S$0.80 B1.79%
2020-12-31S$0.79 B57.55%
2019-12-31S$0.50 B-17.49%
2018-12-31S$0.61 B66.54%
2017-12-31S$0.36 B-62.56%
2016-12-31S$0.97 B23.52%
2015-12-31S$0.79 B583.55%
2014-12-31S$0.11 B11.91%
2013-12-31S$0.10 B107.4%
2012-12-31S$49.97 M-4.01%
2011-12-31S$52.06 M-15.12%
2010-12-31S$61.33 M222.75%
2009-12-31S$19 M-76.98%
2008-12-31S$82.55 M-10.07%
2007-12-31S$91.8 M-56.35%
2006-12-31S$0.21 B95.84%
2005-12-31S$0.10 B
2003-12-31S$9.81 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Biogen
BIIB
S$14.25 B 1,623.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$2.01 B 144.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$1.05 B 27.73%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$79.41 B 9,499.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
S$0.11 B-86.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
S$69.77 B 8,333.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark